Business Context and Reporting Period
This Form 8-K Current Report is filed by DaVita HealthCare Partners Inc. on March 27, 2015. The report addresses a significant change in executive leadership regarding the Chief Financial Officer position.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure of CFO: Garry E. Menzel is stepping down as Chief Financial Officer effective March 30, 2015.
- Transitional Role: Mr. Menzel will remain with the company in a transitional capacity for a period to be mutually determined.
- Appointment of Interim CFO: James K. Hilger, currently the Chief Accounting Officer, will assume the role of Interim Chief Financial Officer effective March 30, 2015.
Management Commentary and Compensation
James K. Hilger has extensive prior experience within the company, having served as Vice President and Controller since May 2006 and as acting or Interim CFO on two previous occasions (2007-2008 and 2012-2013). His base salary will remain at $350,000, a rate effective since April 2014. The filing includes a press release dated March 27, 2015, as Exhibit 99.1.
Investor Verification Checklist
- Confirm the exact date of Garry E. Menzel's final day as CFO (March 30, 2015).
- Verify the duration of Mr. Menzel's transitional role, as no specific end date is provided.
- Review the attached press release (Exhibit 99.1) for additional context on the leadership transition.
- Monitor future filings for the appointment of a permanent Chief Financial Officer.